CALLISTO PHARMACEUTICALS INC
CIK 0001142380
Revenue (TTM)
—
Q3 Nov 2012
Net Income (TTM)
$109.36M
+73.7% YoY
Q3 Nov 2012
EPS Diluted (TTM)
$0.70
Q3 Nov 2012
Gross Margin
—
Q3 Nov 2012
Operating Margin
—
Q3 Nov 2012
Net Margin
—
Q3 Nov 2012
Free Cash Flow (TTM)
—
Q3 Nov 2012
Cash
$120
Q3 Nov 2012
Total Debt
—
Q3 Nov 2012
Shares Outstanding
158.97M sh
Q3 Nov 2012
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.